Stevanato Group S.p.A (STVN) Interest & Investment Income (2020 - 2026)
Stevanato Group S.p.A (STVN) reported Interest & Investment Income of $3.9 million for Q1 2026, down 37.73% year-over-year from $6.3 million in Q1 2025, and down 75.84% quarter-over-quarter from $16.3 million in Q3 2025.
Stevanato Group S.p.A (STVN) Interest & Investment Income (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has 7 years of Interest & Investment Income data on file, last reported at $3.9 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $3.9 million, down 37.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 37.73% YoY), and the FY2025 annual result was $15.1 million, up 4.66% from the prior year.
- Interest & Investment Income retreated to $3.9 million in Q1 2026 per STVN's latest filing, from $16.3 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $17.4 million in Q3 2022 and troughed at $2.9 million in Q1 2024.
- A 5-year average of $10.2 million and a median of $10.1 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2025: Interest & Investment Income tumbled 48.1% in 2024, then jumped 154.91% in 2025.
- A 5-year view of Interest & Investment Income shows it stood at $17.4 million in 2022, then declined by 0.15% to $17.4 million in 2023, then fell by 16.86% to $14.4 million in 2024, then advanced by 12.77% to $16.3 million in 2025, then slumped by 75.84% to $3.9 million in 2026.
- Business Quant data shows STVN's Interest & Investment Income at $3.9 million in Q1 2026, $16.3 million in Q3 2025, and $17.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -136.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 12.29 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 5.10 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -62.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 3.91 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -66.00 Mn |
| 10 | Stevanato Group S.p.A | 433.37 Mn | 290.42 Mn | 88.01 Mn | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Sep 30, 2025 | 16.27 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 6.31 Mn |
| Dec 31, 2024 | 14.43 Mn |
| Sep 30, 2024 | 9.01 Mn |
| Jun 30, 2024 | 6.74 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Sep 30, 2023 | 17.35 Mn |
| Jun 30, 2023 | 12.12 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Sep 30, 2022 | 17.38 Mn |
| Jun 30, 2022 | 11.20 Mn |
| Mar 31, 2022 | 3.34 Mn |
| Sep 30, 2021 | 7.53 Mn |
| Jun 30, 2021 | 5.18 Mn |
| Mar 31, 2021 | 2.42 Mn |
| Sep 30, 2020 | 13.90 Mn |
| Jun 30, 2020 | 10.46 Mn |